MedTrace Logo

Effect of Probiotics on Mycoplasma Pneumoniae Pneumonia

NCT06348095 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-03-03

No results posted yet for this study

Summary

To evaluate the effectiveness and safety of compound probiotic in shortening the course of illness in children with mycoplasma pneumoniae pneumonia, in comparison with placebo.

Conditions

  • Mycoplasma Pneumoniae Pneumonia

Interventions

DIETARY_SUPPLEMENT

Probiotic

The experimental phase of this study had last 14 days, and each patient will make 4 visits (d0, at discharge, d14).

DIETARY_SUPPLEMENT

Placebo

The experimental phase of this study had last 14 days, and each patient will make 4 visits (d0, at discharge, d14).

Sponsors & Collaborators

  • Wecare Probiotics Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2025-03-20
Completion
2025-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06348095 on ClinicalTrials.gov